Emeramide clinical trials
Also written NBMI.
How each study uses emeramide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Keep track of what changes. Save the emeramide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesApprovals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
EmeraMed (5)
Related medicines
As reviewed, each with the page that says it.
- One of Chelating Agents source
Studies
Open first, then newest update. How each study uses emeramide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- NBMI Treatment in Patients With Mercury ToxicityRecruitingPhase 2/3EmeraMedNCT04183595Written as (N1, N3-bis(2- mercaptoethyl)isophthalamide)
- Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)CompletedPhase 2EmeraMedNCT04184063Written as NBMI
- Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron ChelationCompletedPhase 2EmeraMedNCT04092205Written as Emeramide
- Pilot Proof of Concept Study of NBMI Treatment of Mercury IntoxicationCompletedPhase 2EmeraMedNCT02486289Written as Emeramide
- NBMI - Clinical Study on COPDCompletedPhase 2EmeraMedNCT03123692Written as Emeramide
Codes
What other systems call emeramide · ClinicalTrials.gg INT001055
- MeSH (NLM) C000629929N,N'-Bis(2-mercaptoethyl)isophthalamideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 4U7K5X4ANSEMERAMIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q1959945emeramideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166785EmeramideOne source FDA
- DrugBank DB12192One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000629929 | N,N'-Bis(2-mercaptoethyl)isophthalamide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 4U7K5X4ANS | EMERAMIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q1959945 | emeramide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166785 | Emeramide | One source FDA |
| DrugBank | DB12192 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.